Xinhua Pharmaceutical (000756.SZ) obtains the drug registration certificate for sildenafil citrate orally disintegrating tablets.

Zhixin Financial APP News, Xinhua Pharmaceutical (000756.SZ) announced that the company has received the "Drug Registration Certificate" issued by the National Medical Products Administration for the approval of the mouth-disintegrating tablets of Sildenafil Citrate. The announcement indicates that Sildenafil Citrate mouth-disintegrating tablets are used to treat erectile dysfunction.